Ticker Search:  Getting Started | Register | Videos | Newsletter | Partners | Login    

Basics
Aclaris Therapeutics, Inc.
Aclaris Therapeutics Inc is a clinical-stage specialty pharmaceutical company which focuses on identifying, developing and commercializing differentiated drugs to address significant unmet needs in dermatology.
IPO Date: October 7, 2015
Sector: Healthcare
Industry: Biotech
Market Cap: $164.59M
Activated in VL: True
Average Daily Range
Avg Daily Range: $0.35 | 3.17%
Avg Daily Range (30 D): $0.04 | 2.52%
Avg Daily Range (90 D): $0.04 | 3.10%
Institutional Daily Volume
Avg Daily Volume: .67M
Avg Daily Volume (30 D): .66M
Avg Daily Volume (90 D): .73M
Trade Size
Avg Trade Size (Sh.): 151
Avg Trade Size (Sh.) (30 D): 158
Avg Trade Size (Sh.) (90 D): 164
Institutional Trades
Total Inst.Trades: 1,174
Avg Inst. Trade: $1.57M
Avg Inst. Trade (30 D): $4.47M
Avg Inst. Trade (90 D): $3.34M
Avg Inst. Trade Volume: .14M
Avg Inst. Trades (Per Day): 1
Market Closing Trades
Avg Closing Trade: $1.5M
Avg Closing Trade (30 D): $10.84M
Avg Closing Trade (90 D): $6.68M
Avg Closing Volume: 142.04K
   
News
May 9, 2025 @ 11:00 AM
Aclaris Therapeutics to Participate in the HC Wain...
Source: N/A
Apr 29, 2025 @ 11:00 AM
Aclaris Therapeutics Appoints Jesse Hall, M.D. as ...
Source: N/A
Mar 3, 2025 @ 6:00 PM
JAK Inhibitors Clinical Trial Pipeline Appears Rob...
Source: Delveinsight
Sep 10, 2024 @ 11:00 AM
Aclaris Therapeutics to Participate in the 2024 Ca...
Source: N/A
Jul 23, 2024 @ 11:31 AM
Aclaris Therapeutics And 3 Other Stocks Under $2 I...
Source: Avi Kapoor
Financials
  TTM Q1 2025 Q4 2024
Basic EPS $-1.59 $-.12 $-1.21
Diluted EPS $-1.59 $-.12 $-1.21
Revenue $ 17.78M $ 1.46M $ 9.21M
Gross Profit $ 15.29M $ .95M $ 8.51M
Net Income / Loss $ -130.21M $ -15.09M $ -96.55M
Operating Income / Loss $ -141.09M $ -18.08M $ -99.68M
Cost of Revenue $ 2.49M $ .51M $ .71M
Net Cash Flow $ -5.48M $ 5.79M $ -23.08M
PE Ratio